Skip to main content

1 Result(s)

within J. Wallin Remove this filter Molecular Medicine Remove this filter

and

  1. Article

    Open Access

    Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer

    This single-arm phase II study investigated the EGFR monoclonal antibody necitumumab plus modified FOLFOX6 (mFOLFOX6) in first-line treatment of locally advanced or metastatic colorectal cancer (mCRC).

    E Elez, A Hendlisz, T Delaunoit, J Sastre, A Cervantes… in British Journal of Cancer (2016)

    Download PDF (333 KB) View Article